Table 1.
Patient Characteristicsa.
Liposomal Bupivacaine Group (N = 33) | Control Group (N = 26) | P | |
---|---|---|---|
Male: female | 21:12 | 9:17 | .652 |
Age | 59.8 (12.22) | 63.1 (10.6) | .271 |
BMI | 29.9 (6.38) | 30.5 (6.3) | .736 |
CCI scores | 3.0 (0.39) | 2.5 (0.37) | .29 |
Length of stay (days) | 3.9 (1.62) | 3.9 (1.46) | .92 |
Number of vertebrae fused | 2.7 (1.0) | 2.4 (0.50) | .093 |
Number of vertebrae decompressed | 3.1 (1.0) | 3.7 (0.91) | .036 |
EBL (mL) | 428.9 (337.7) | 450.9 (262.5) | .780 |
Operation length (minutes) | 147.4 (54.3) | 168.7 (56.2) | .161 |
Abbreviations: BMI, body mass index; CCI, Charlson comorbidity index20; EBL, estimated blood loss.
aValues presented as means (SDs).